Promoter holding
64.27%
EF
Emami Frank Ross Limited - Due diligence report
A 360° intelligence report on Frank Ross Pharmacy: trust score, financial health, credit view, compliance, directors, growth and distress si…
Full Due-Diligence Report + Documents
- Unlock all financial figures & 5-year trends
- Full trust, health & credit-risk scores
- Director details, charges & MCA documents
₹700
₹449
Save ₹251
excl. GST
Or from ₹279/report with credits
View credit packages
Company Credits – Starter
- One credit unlocks this full due-diligence report
- Use across any company’s report, anytime
- Credits valid for 12 months
Choose your own credit amount
View credit packages
Frank Ross Pharmacy — 360° Intelligence Report
Generated from MCA filings & public records61/100
Trust Score
Moderate
Frank Ross Pharmacy is assessed as Moderate with a Trust Score of 61/100. Frank Ross Pharmacy is an active public limited indian non-government company incorporated in 1919, operating in the E-Commerce sector. The company has shown revenue growth across its recent filed years. It reported a loss in its latest filed year. Based on MCA filings and public records, it currently shows a moderate compliance risk and high financial risk profile.
Report generated on 16 Jul 2026 from the latest processed filings. Emami Frank Ross Limited snapshot & full profile →
Automated indicators derived from public MCA / GST / EPFO records - not a credit rating, not investment, legal or financial advice. Spotted an inaccuracy? Report an error.
02
Score Card
Higher is safer · rule-based & explainableTrust ScoreModerate
61/100
Overall counterparty trust - the headline number of this report.
Compliance ScoreModerate
74/100
Statutory standing - status, filings, auditor, MSME and litigation.
Financial Health ScoreCaution Indicated
25/100
Profitability, leverage and liquidity from filed statements.
Credit Risk ScoreModerate
50/100
Debt capacity, gearing and security cover for lenders.
Director Stability ScoreLow Risk
80/100
Board strength, DIN status, churn and network.
Growth ScoreModerate
70/100
Revenue, profit, asset and hiring momentum.
Distress ScoreCaution Indicated
35/100
Early-warning signals - higher means fewer warnings.
03
Financial Intelligence Dashboard
Standalone · 5 filed year(s)Unlock the full 5-year financial dashboard with charts and year-wise figures.
Get full accessScores and observations on this page are already computed from the real filings - only the underlying figures are locked.
04
Credit & Compliance Intelligence
Why the scores are what they are
Credit Risk Score: 50/100 Moderate
- Liabilities ≈ 38% EBITDA - stretched.
- Working-capital cover adequate.
- Externally credit-rated (BBB).
Charges position: 13 open (648.12 cr) · 21 satisfied (2,472.38 cr).
Banking relationships (from registered charges)
| Lender | Charges | Amount |
|---|---|---|
| Idbi Trusteeship Services Limited | 3 | 48.0 cr |
| Others | 15 | 48.0 cr |
| Indusind Bank Ltd. | 2 | 48.0 cr |
| Axis Bank Ltd | 1 | 48.0 cr |
| Industrial Development Bank Of India | 4 | 48.0 cr |
| Hdfc Bank Limited | 2 | 48.0 cr |
Compliance Score: 74/100 Moderate
- Company status is Active as per MCA.
- Balance sheet slightly behind (Mar 2024).
- Litigation present in 2 court forum(s).
- 10 active GST registration(s).
Legal cases on record (2)
05
Director Intelligence
Stability score: 80/100| Name | DIN / PAN | Designation | Appointed | Tenure | DIN status |
|---|---|---|---|---|---|
| KARABI SENGUPTA | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| CHADARAVALLI SRINIVASABHATTA NALINI | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| PRIYANKA AGARWAL | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| HARI MOHAN MARDA | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| Gautam Jatia | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| RAVI KUMAR SHARMA | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| GAUTAM JATIA | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| Shivani Marda | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| ANURAG JATIA | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| SUJOY CHATTARAJ | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
- 10 directors on the board.
- No disqualified or deactivated DINs.
- 6 director exits in 3 years - high churn.
- Average tenure above 5 years.
Director & KMP remuneration (FY 2023)
| Name | Designation | Total remuneration |
|---|---|---|
| A K Sharma | Managing Director | 2.4 cr |
| R Mehta | Whole-time Director | 1.6 cr |
| S Iyer | CFO | 95.0 L |
Remuneration is disclosed in the latest annual return. Unlock full report
06
Ownership & Group Intelligence
As per FY 2023 annual returnPublic / other holding
35.73%
Equity shares
12,45,67,890
Equity paid-up
124.5 cr
Promoters on record
4
Ultimate holding entity
-
Subsidiaries
1
Group entities
1
Capital events
9 allotment(s) · 0 transfer(s)
Promoters hold a dominant controlling stake - exact percentages are part of the full report.
| Group entity | Relationship | % held |
|---|---|---|
| Lyfresh Private Limited | Subsidiary Company | 74.00% |
Key managerial personnel: CHADARAVALLI SRINIVASABHATTA NALINI (Whole-time director) · Gautam Jatia (CEO) · GAUTAM JATIA (Managing Director) · ANURAG JATIA (Whole-time director) · SUJOY CHATTARAJ (Whole-time director)
Full shareholding pattern, group structure & capital events →
07
Risk Intelligence Center
Growth 70 · Distress 35
Growth signals & trust indicators
Steady revenue growth: +1.42 over 4 year(s).
Asset base grew 2.1x - capacity expansion.
EPFO headcount growing - hiring signal.
Operating for 107+ years.
Active EPFO - real payroll on record.
Active GST registration(s).
Distress signals & risk flags
Losses deepening year-on-year.
Outside liabilities up 24% in a year.
Negative net worth.
5 director exits within 2 years.
13 open charge(s) registered - assets are encumbered.
2 court case(s) on record - see the legal section for details.
08
Stakeholder Verdicts
Vendor · Banker · InvestorVendor due diligence58/100
Review suggested
Suitability as a supplier / customer counterparty.
- Statutory record is clean.
- 4 distress signal(s) - see Risk Center.
- Financial filings available for verification.
Banker assessment48/100
Mixed indicators - deeper appraisal suggested
Indicative lending comfort for banks, NBFCs and trade credit.
- Debt capacity assessed from filed statements.
- 13 open charge(s) of 648.12 cr already registered.
- Compliance record supports lending.
Investor view52/100
Mixed indicators
Growth quality and scalability through an investor lens.
- 3 growth signal(s) detected.
- Margin and return trends computable from filings.
- Management team looks stable.
09
MCA Filings & Events Timeline
Latest 15 events23 Sep 2025
Last AGM held
Annual general meeting
22 Sep 2025
Director ceased
RAVI KUMAR SHARMA
05 Sep 2025
Director appointed
Shivani Marda (Company Secretary)
12 Feb 2025
Director appointed
RAVI KUMAR SHARMA (Director)
31 Dec 2024
Charge created
Others - 8.00 Lakh
29 Sep 2024
Director ceased
HARI MOHAN MARDA
Director ceased
RAM GOBIND GANERIWALA
26 Sep 2024
Charge created
Hdfc Bank Limited - 35.00 cr
12 Sep 2024
Charge created
Others - 105.00 cr
14 Aug 2024
Director ceased
PRAMOD KUMAR SHAH
17 Jul 2024
Director ceased
DEBASISH BHAUMIK
31 May 2024
Director ceased
BIMAL KUMAR AGARWAL
29 May 2024
Director appointed
HARI MOHAN MARDA (Director)
31 Mar 2024
Latest balance sheet
Filed with ROC
21 Feb 2024
Director appointed
PRIYANKA AGARWAL (Company Secretary)
10
Key Observations
Auto-generated from the data aboveRevenue grew 0.86 over the last 4 financial year(s).
Net profit margin moved from 61% to 38%.
10 active director(s) / partner(s); board looks stable and experienced.
10 active GST registration(s) indicate ongoing business operations.
Operates a group structure with 1 subsidiary(ies) - assess on a consolidated basis.
Carries an external credit rating of BBB from Care.
EPFO-registered employer - verifiable payroll history exists.
Promoters hold a dominant controlling stake as per the FY 2023 annual return.
Director / KMP remuneration is disclosed in the latest annual return - exact figures available in the full report.
Capital has been raised through 9 security allotment(s) - amounts available in the full report.
| Company | CIN | Location |
|---|---|---|
| Kun Capital Automotive Private Limited | U74990TN2011PTC081199 | Ambattur, Tamil Nadu, India |
| Shree Motors Private Limited | U34102HR1986PTC025109 | Faridabad, Haryana, India |
| Jai Beverages | U15511MH1999PTC461217 | Mumbai, Maharashtra, India |
| Anant Cars | U50102KA2012PTC066014 | Bangalore South, Karnataka, India |
| Cpr Distributors | U51102MP1998PTC013162 | Indore, Madhya Pradesh, India |
| O.S.Automobiles Private Limited | U51109RJ1996PTC011722 | Jodhpur, Rajasthan, India |
| Antony Commercial Vehicles Private Limited | U50200MH2011PTC215262 | Navi Mumbai, Maharashtra, India |
| Surana Ensemble Private Limited | U51909KA2022PTC158808 | Bangalore North, Karnataka, India |
12
Who Uses This Report
CA · CS · Banker · Investor · VendorChartered Accountants (CA)
Verify Frank Ross Pharmacy before audits and certifications: compliance score 74/100, filing history, auditor history and charge records in one place - instead of pulling each MCA form separately.
Company Secretaries (CS)
Track statutory health of Frank Ross Pharmacy: ACTIVE compliance status, annual-return recency, director DIN status, board churn and the events timeline - the inputs for secretarial audits and due-diligence certificates.
Bankers & NBFCs
Current banker verdict: Mixed indicators - deeper appraisal suggested. Credit risk score 50/100, existing charge position and lender relationships - a first-pass credit memo before formal appraisal.
Investors & Analysts
Investor view: Mixed indicators. Growth score 70/100, margin trends, ownership structure and peer set for Frank Ross Pharmacy - screening before a deeper diligence.
Vendors & Procurement Teams
Vendor verdict: Review suggested. Trust score 61/100, distress signals and MSME payment-delay disclosures - know whether Frank Ross Pharmacy pays its suppliers before you extend credit terms.
Lawyers & Compliance Teams
Litigation footprint (2 case(s) on record), regulatory flags, charge documents trail and director networks for Frank Ross Pharmacy - groundwork for KYC, onboarding and disputes.
13
Frequently Asked Questions
Is Frank Ross Pharmacy an active company?
Frank Ross Pharmacy has MCA status “Active” with a compliance score of 74/100 (Moderate).
Is Frank Ross Pharmacy financially healthy?
Frank Ross Pharmacy has a Financial Health Score of 25/100 (Caution Indicated) based on its filed financial statements.
Should I do business with Frank Ross Pharmacy?
Its overall Trust Score is 61/100 (Moderate). Vendor verdict: Review suggested. Review the risk flags in the Risk Intelligence Center before deciding.
Who controls Frank Ross Pharmacy?
Promoters hold a dominant controlling stake - exact percentages are in the full report. 10 active director(s) are on record.
Does Frank Ross Pharmacy have loans or charges against its assets?
13 open charge(s) are registered against its assets, and 21 earlier charge(s) stand satisfied.
Is Frank Ross Pharmacy up to date with its ROC filings?
Balance sheet slightly behind (Mar 2024). Overall compliance score: 74/100 (Moderate).
Is it risky to lend to Frank Ross Pharmacy?
Its Credit Risk Score is 50/100 (Moderate). Banker verdict: Mixed indicators - deeper appraisal suggested.
Disclaimer: This report is generated automatically from MCA filings and public records as available
in our system at the time of the last update. Scores, bands and verdicts are rule-based derived indicators of the
underlying data - they are opinions generated by an algorithm, not statements of fact about the company, and are
not credit ratings (within the meaning of SEBI regulations), audits, or investment, legal or financial advice.
Verify from official sources and consult a qualified professional before any business, lending or investment decision.
If you represent this company and believe any information is inaccurate or outdated,
report it here and we will review promptly.
